____________________________________________________________________________________________________________________
© 2005-12  All Rights Reserved. NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc., an innovative biotech company focusing on oral biopharmaceutical
delivery, is quickly becoming the leader in this field.  A platform technology, NOD tech, is developed to
overcome the barriers of oral bio-drugs and to enable oral delivery of biopharmaceuticals.

The unique feature of NOD tech allows high efficient oral  absorption of bio-drugs and modulation of
pharmacokinetic profile, in contrasting to competing technologies.  For details, please visit
technology.

Many candidates have been tested with NOD tech and an oral insulin formulation has been developed
for basal insulin supplementation.  The feasibility of oral insulin in human subject has been confirmed in
Phase 1 studies.  Please refer to
Product for details.
Emerging Leader in Oral Delivery of Biopharmaceuticals
-Innovation Delivered
News